Bacteriocins are highly targeted
Microbiome Modulation
Targeted activity enables selective eradication of specific bacterial strains, carving out niches within the microbiome. This allows for the growth and flourishing of beneficial bacteria, fostering a more diverse and resilient microbial ecosystem.
Minimal Toxicity
Bacteriocins evolved to target bacteria — not human, plant, or other mammalian cells
Negligible Resistance
Specificity minimizes the chances of bacteria developing resistance, unlike broad-spectrum antibiotics which affect a wide range of bacteria, leading to increased chances of resistance development.
Reduced Collateral Damage
Selectively inhibiting bacteria reduces unintended impacts on beneficial microbiota. Broad-spectrum antibiotics can harm beneficial bacteria, disrupting the natural balance of the microbiome.
Enhanced Efficacy
Precision avoids the inefficiencies of broad-spectrum antibiotics, which can unnecessarily target non-problematic bacteria.